These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


118 related items for PubMed ID: 9488202

  • 1. Inhibition of platelet activity in vivo by amlodipine alone and combined with aspirin.
    Folts JD.
    Int J Cardiol; 1997 Dec 31; 62 Suppl 2():S111-7. PubMed ID: 9488202
    [Abstract] [Full Text] [Related]

  • 2. Effect of aspirin and epinephrine on experimentally induced thrombogenesis in dogs. A parallelism between in vivo and ex vivo thrombosis models.
    Roux SP, Sakariassen KS, Turitto VT, Baumgartner HR.
    Arterioscler Thromb; 1991 Dec 31; 11(5):1182-91. PubMed ID: 1911705
    [Abstract] [Full Text] [Related]

  • 3. The use of amlodipine, but not of P-glycoprotein inhibiting calcium channel blockers is associated with clopidogrel poor-response.
    Harmsze AM, Robijns K, van Werkum JW, Breet NJ, Hackeng CM, Ten Berg JM, Ruven HJ, Klungel OH, de Boer A, Deneer VH.
    Thromb Haemost; 2010 May 31; 103(5):920-5. PubMed ID: 20352154
    [Abstract] [Full Text] [Related]

  • 4. Epinephrine potentiation of in vivo stimuli reverses aspirin inhibition of platelet thrombus formation in stenosed canine coronary arteries.
    Folts JD, Rowe GG.
    Thromb Res; 1988 May 15; 50(4):507-16. PubMed ID: 3413717
    [Abstract] [Full Text] [Related]

  • 5. High-dose droperidol protects against experimental coronary thrombosis in dogs and pigs and attenuates aggregation of porcine platelets and Ca2+ mobilization in human platelets.
    Bertha BG, Sill JC, Berger I, Folts JD, Milde JH.
    Anesthesiology; 1993 Apr 15; 78(4):733-43. PubMed ID: 8466073
    [Abstract] [Full Text] [Related]

  • 6. In vivo inhibition of platelet aggregation and occlusive coronary thrombus formation by a new calcium antagonist (R023-6152).
    Sordahl LA, Rex KA, Benedict CR.
    J Cardiovasc Pharmacol; 1991 Oct 15; 18(4):504-10. PubMed ID: 1724526
    [Abstract] [Full Text] [Related]

  • 7. Failure of calcium channel blockade to reduce platelet-mediated cyclic flow variations in dogs with coronary stenosis and endothelial injury.
    Beaughard M, Brasset M, John G, Massingham R.
    J Cardiovasc Pharmacol; 1995 Oct 15; 26(4):577-83. PubMed ID: 8569218
    [Abstract] [Full Text] [Related]

  • 8. Antiplatelet effect of aspirin in patients with coronary artery disease.
    Grove EL.
    Dan Med J; 2012 Sep 15; 59(9):B4506. PubMed ID: 22951204
    [Abstract] [Full Text] [Related]

  • 9. Antithrombotic effects of MK-0852, a platelet fibrinogen receptor antagonist, in canine models of thrombosis.
    Ramjit DR, Lynch JJ, Sitko GR, Mellott MJ, Holahan MA, Stabilito II, Stranieri MT, Zhang G, Lynch RJ, Manno PD.
    J Pharmacol Exp Ther; 1993 Sep 15; 266(3):1501-11. PubMed ID: 8371153
    [Abstract] [Full Text] [Related]

  • 10. Prevention of experimental carotid and coronary artery thrombosis by the glycoprotein IIb/IIIa receptor antagonist CRL42796.
    Hennan JK, Hong TT, Willens DE, Driscoll EM, Giboulot TA, Lucchesi BR.
    Br J Pharmacol; 2002 Jul 15; 136(6):927-37. PubMed ID: 12110617
    [Abstract] [Full Text] [Related]

  • 11. Comparative effects of anti-platelet agents as adjuncts to tissue plasminogen activator in a dog model of occlusive coronary thrombosis.
    McAuliffe SJ, Moors JA, Jones HB.
    Br J Pharmacol; 1994 May 15; 112(1):272-6. PubMed ID: 8032650
    [Abstract] [Full Text] [Related]

  • 12. Glycoprotein Ibalpha inhibition and ADP receptor antagonists, but not aspirin, reduce platelet thrombus formation in flowing blood exposed to atherosclerotic plaques.
    Penz SM, Reininger AJ, Toth O, Deckmyn H, Brandl R, Siess W.
    Thromb Haemost; 2007 Mar 15; 97(3):435-43. PubMed ID: 17334511
    [Abstract] [Full Text] [Related]

  • 13. Effects of selective cyclooxygenase-2 inhibition on vascular responses and thrombosis in canine coronary arteries.
    Hennan JK, Huang J, Barrett TD, Driscoll EM, Willens DE, Park AM, Crofford LJ, Lucchesi BR.
    Circulation; 2001 Aug 14; 104(7):820-5. PubMed ID: 11502709
    [Abstract] [Full Text] [Related]

  • 14. Human platelet Ca2+ mobilization, glycoprotein IIb/IIIa activation, and experimental coronary thrombosis in vivo in dogs are all inhibited by the inotropic agent amrinone.
    Sill JC, Bertha B, Berger I, Uhl C, Nugent M, Folts J.
    Circulation; 1997 Sep 02; 96(5):1647-53. PubMed ID: 9315560
    [Abstract] [Full Text] [Related]

  • 15. Effects of GP IIb/IIIa receptor monoclonal antibody (7E3), heparin, and aspirin in an ex vivo canine arteriovenous shunt model of stent thrombosis.
    Makkar RR, Litvack F, Eigler NL, Nakamura M, Ivey PA, Forrester JS, Shah PK, Jordan RE, Kaul S.
    Circulation; 1997 Feb 18; 95(4):1015-21. PubMed ID: 9054765
    [Abstract] [Full Text] [Related]

  • 16. Potent low dose platelet inhibitory effects of clopidogrel and aspirin on coronary thrombus formation in an animal model of acute unstable angina.
    Bierbach B, Horstick G, Berg O, Heimann A, Münzel T, Vahl CF, Kempski O, Darius H.
    Thromb Haemost; 2006 Feb 18; 95(2):354-61. PubMed ID: 16502561
    [Abstract] [Full Text] [Related]

  • 17. Thrombostatin inhibits induced canine coronary thrombosis.
    Hasan AA, Rebello SS, Smith E, Srikanth S, Werns S, Driscoll E, Faul J, Brenner D, Normolle D, Lucchesi BR, Schmaier AH.
    Thromb Haemost; 1999 Sep 18; 82(3):1182-7. PubMed ID: 10494785
    [Abstract] [Full Text] [Related]

  • 18. Effects of cigarette smoke and nicotine on platelets and experimental coronary artery thrombosis.
    Folts JD, Gering SA, Laibly SW, Bertha BG, Bonebrake FC, Keller JW.
    Adv Exp Med Biol; 1990 Sep 18; 273():339-58. PubMed ID: 2288288
    [Abstract] [Full Text] [Related]

  • 19. Mouse antithrombotic assay: the effects of Ca++ channel blockers are platelet-independent.
    Molinari A, Guarneri L, Pacei E, de Marchi F, Cerletti C, de Gaetano G.
    J Pharmacol Exp Ther; 1987 Feb 18; 240(2):623-7. PubMed ID: 3806414
    [Abstract] [Full Text] [Related]

  • 20. Effects of clopidogrel, aspirin and combined therapy in a porcine ex vivo model of high-shear induced stent thrombosis.
    Makkar RR, Eigler NL, Kaul S, Frimerman A, Nakamura M, Shah PK, Forrester JS, Herbert JM, Litvack F.
    Eur Heart J; 1998 Oct 18; 19(10):1538-46. PubMed ID: 9820993
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.